Caption Management »

Merrimack Pharma shares owned by Caption Management

Quarter-by-quarter ownership of Merrimack Pharma (MACK) shares owned by Caption Management from 13F filings

Historical chart of Caption Management investment in Merrimack Pharma

Tip: Access up to 7 years of quarterly data

All positions including Merrimack Pharma held by Caption Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Merrimack Pharma by Caption Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.7M 126k 13.41
2023-09-30 $1.4M 112k 12.33

More positions owned by Caption Management

Cytokinetics Com New Call Option (CYTK)
Verizon Communications Put Option (VZ)
Metropcs Communications Call Option (TMUS)
Citigroup Com New Put Option (C)
Mondelez Intl Cl A Put Option (MDLZ)
stock Call Option
Spdr Ser Tr S&p Regl Bkg Put Option (KRE)
Kenvue Call Option (KVUE)
Palo Alto Networks Put Option (PANW)
Sarepta Therapeutics Call Option (SRPT)
Spdr Ser Tr S&p Biotech Call Option (XBI)
United States Steel Corporation Call Option (X)
Tal Education Group Sponsored Ads Call Option (TAL)
Zillow Group Cl C Cap Stk Call Option (Z)
Agnico Call Option (AEM)

View all positions for Caption Management

Top funds holding Merrimack Pharma

Western Standard
Newtyn Management
Vanguard Group
Madison Avenue Partners
ADAR1 Capital Management
Dimensional Fund Advisors
Sepio Capital
Indaba Capital Management
Wittenberg Investment Management
Caption Management
Bank of New York Mellon
Kennedy Capital Management
Goldman Sachs Group
Citadel Advisors
Charles Schwab Investment Management

View all funds holding Merrimack Pharma